content

Abzena, the leading end-to-end CDMO for complex biologics and bioconjugates, has co-authored a publication with the US FDA demonstrating the potential of the MHC...

Veeva Systems announced that Anthem Biosciences, a rapidly expanding contract research and innovation service provider (CRISP), has successfully implemented Veeva Vault Quality across all...

The introduction of gene therapies and therapeutic proteins has marked a revolutionary step in combating disease. However, these advanced treatments must navigate the challenging...

For emerging drug developers, the shift from lab to clinic is a transition that can lay the groundwork for success at many future milestones...

It is well worth noting that the last few years have seen a rapid period when it comes to technological adoption in the life...

Massive transitions in the healthcare market have gone on to push the pharma sector into some painful shifts in the years that have gone...

It becomes imperative that innovations keep upgrading in the pharmaceutical sector, be it clinical trials or the supply chain. As drug development and storage...